Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on immunotherapy efficacy in advanced hepatocellular carcinoma. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback